| |
The National Stock Exchange of India Limited has expelled the trading member Acumen Securities Ltd, with effect from July 1, 2003, due to failure of the member to resolve the investor complaints lodged with the Exchange.
The trading facility of the member was withdrawn since October 17,2002.
Consequently, National Securities Clearing Corporation Ltd. has also expelled the said clearing member Acumen Securities Ltd, with effect from July 1, 2003.
Top
The National Stock Exchange of India Limited has expelled the trading member Esskyennr Securities Ltd, with effect from July 1, 2003, due to failure of the trading/clearing member in meeting the capital requirements for continued admittance to the trading/clearing membership of the Exchange/Clearing Corporation.
The trading facility of the member was withdrawn since August 14,2001 and was suspended since August 1,2002.
Consequently, National Securities Clearing Corporation Ltd. has also expelled the said clearing member Esskyennr Securities Ltd, with effect from July 1, 2003.
Top
The National Stock Exchange of India Limited has suspended the trading member Yelkayes Financial Consultants & Investments Ltd, with effect from July 1, 2003, due to failure of the trading member in meeting the capital requirements for continued admittance to the trading/clearing membership of the Exchange/Clearing Corporation.
The trading facility of the member was withdrawn since August 1, 2002.
Consequently, National Securities Clearing Corporation Ltd. has also suspended the said clearing member Yelkayes Financial Consultants & Investments Ltd, with effect from July 1, 2003.
.
Top
The press had reports that Wockhardt Life Sciences Limited has sold its 95.81% stake in drugmaker, Merind, to a promoter company booking a loss of Rs 86 crore.
The Exchange, in order to verify the accuracy or otherwise of the information reported in the press and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company.
Wockhardt Life Sciences Limited has vide its letter inter-alia stated, "You may please note that as part of its restructuring exercise the Company had sold the stake in Merind to Khorakiwala Holdings & Investments Pvt. Ltd. which is the holding Company of Wockhardt Life Sciences Limited. The said sale was also informed by the Company in its financial results for the quarter ended September, 2002 and has also been adequately informed in the Annual Report of the Company for the year ended December 2002."
Top
The press had reports that ITC was looking to acquire the cigarette business of GTC Industries Limited.
The Exchange, in order to verify the accuracy or otherwise of the information reported in the press and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the companies.
GTC Industries Ltd has vide its letter inter-alia stated, "At the outset, we deny the rumour as no such developments are going on atleast to the knowledge of the Company's management."
Reply is awaited from ITC Limited.
Top
The Exchange has successfully completed its 837th and 838th Normal Settlement (Rolling T+2 following SEBI directive) since inception i.e., Settlement Number N – 2003122 and N - 2003123 on July 01, 2003. The settlement statistics are as follows:
| Particulars |
Values |
| |
N - 2003122 |
N - 2003123 |
| Total traded quantity (lakhs) |
2519.74 |
2822.57 |
| Total traded value (Rs. In Crores) |
3738.90 |
3722.43 |
| Total value of the settlement (Securities) (Rs. In Crores) |
923.07 |
730.34 |
| Total value of the settlement (Funds) (Rs. In Crores) |
325.47 |
249.13 |
| Shortages for the settlement |
0.38% |
0.80% |
| % of Delivery ( No. of shares delivered / No. of shares traded ) |
30.84% |
25.45% |
Retail Debt Market has completed its 111th and 112th settlement, details of which are as follows :
| Settlement No. |
Traded Value |
Settlement Value |
| |
|
Securities |
Funds |
| 2003122 |
Rs. 2,81,750.00 / - |
NIL |
Rs. 550.00 / - |
| 2003123 |
Rs. 89,127.50 /- |
Rs. 94,317.30 /- |
Rs. 89,127.50 /- |
Top
|
|